Activity-based costing in pharmaceutical
✍
Stig Jørgensen; Martin Edwards
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 218 KB
Pharmaceutical development costs represent a large and escalating part of sales and profits. In many companies, managers have found that the traditional cost accounting methods are not very useful for improving the efficiency and effectiveness of development activities. To complement traditional sys